CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 18 enrolled
Drug / intervention
Stereotactic Body Radiation Therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02208024
NCT02208024N/ACompleted
CompareCT.gov

Phase I Study to Evaluate the Feasibility of Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body

University of Cincinnati·interventional·Posted Aug 4, 2014·Updated Apr 29, 2022

In Brief

A clinical study evaluating Stereotactic Body Radiation Therapy for Pancreatic Cancer. Completed, enrolled 18 participants across 1 site.

Detailed Summary

The purpose of this study is to test the safety of focused radiation (Stereotactic Body Radiation Therapy, SBRT) on patients with pancreatic cancer that will be removed surgically.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 4, 2014
Enrollment StartAug 27, 2014
Primary CompletionOct 11, 2017
Study CompletionMay 12, 2019
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 11.9 years ago

Interventions

Stereotactic Body Radiation Therapyradiation